Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 233,647 | 209,335 | 209,761 | 246,994 | 263,320 |
| Marketable Securities | 16,110 | 50,727 | 29,842 | 39,206 | 16,980 |
| Receivables | 98,073 | 85,174 | 76,433 | 87,632 | 73,331 |
| Inventories | 115,338 | 81,320 | 60,759 | 59,696 | 56,936 |
| TOTAL | $498,474 | $461,701 | $431,239 | $483,061 | $463,256 |
| Non-Current Assets | |||||
| PPE Net | 30,438 | 31,161 | 32,421 | 31,667 | 31,072 |
| Intangibles | 215,823 | 216,650 | 217,469 | 218,287 | 219,115 |
| Other Non-Current Assets | 41,822 | 39,972 | 40,660 | 44,865 | 50,641 |
| TOTAL | $288,083 | $287,783 | $290,550 | $294,819 | $300,828 |
| Total Assets | $786,557 | $749,484 | $721,789 | $777,880 | $764,084 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,481 | 32,057 | 9,210 | 15,120 | 23,154 |
| Accrued Expenses | 136,116 | 127,897 | 124,622 | 144,245 | 138,535 |
| TOTAL | $158,138 | $168,066 | $142,102 | $167,689 | $169,454 |
| Non-Current Liabilities | |||||
| Long Term Debt | 389,494 | 388,939 | 388,391 | 387,858 | 394,071 |
| Other Non-Current Liabilities | 60,100 | 59,956 | 60,602 | 62,159 | 61,416 |
| TOTAL | $449,594 | $448,895 | $448,993 | $450,017 | $461,393 |
| Total Liabilities | $607,732 | $616,961 | $591,095 | $617,706 | $630,847 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 298,806 | 296,591 | 296,199 | 295,383 | 293,246 |
| Common Shares | 2,942 | 2,923 | 2,922 | 2,918 | 2,890 |
| Retained earnings | -2,754,919 | -2,748,190 | -2,732,493 | -2,684,074 | -2,650,231 |
| Other shareholders' equity | 25,042 | 8,865 | 6,715 | 5,312 | -6,697 |
| TOTAL | $178,825 | $132,523 | $130,694 | $160,174 | $133,237 |
| Total Liabilities And Equity | $786,557 | $749,484 | $721,789 | $777,880 | $764,084 |